texas oncology more breakthroughs. more victories

Share:

 
 

In Memoriam – Byron Chesbro, M.D.


The Texas Oncology family is deeply saddened by the loss of Dr. Byron Chesbro, who died suddenly and unexpectedly in late February.

Dr. Chesbro was board certified in medical oncology and internal medicine. He faithfully served his patients in the El Paso area for more than 37 years. He was medical director of oncology services at Sierra Hospital and chief of staff at Providence Hospital. He was a past president of the El Paso Metro Unit of the American Cancer Society and a founding member of the Texas Society of Clinical Oncology. Dr. Chesbro served on the Quality Oversight Committee of Texas Oncology and as co-chair of the Western Regional Oncology conference.

Dr. Chesbro received his medical degree from the State University of New York, Upstate Medical Center. He completed his internship and residency at the Medical College of Ohio and completed his oncology training as a clinical associate at the National Cancer Institute in Bethesda, Md.

Dr. Chesbro will be remembered for his personal warmth and compassion for his patients, as well as his professional integrity and commitment to find a cure for cancer.

On behalf of his colleagues and friends, Texas Oncology extends its sympathies to Dr. Chesbro’s family, including his wife Melissa and his children.

Services for Dr. Chesbro will be Saturday, March 17, at 2 p.m., at the Church of St. Clement, 810 N. Campbell, El Paso, Texas 79902. The family asks that in lieu of flowers, contributions be made to the Dr. Byron Chesbro Scholarship Fund at Rio Grande Cancer Foundation.


About Texas Oncology

Texas Oncology is an independent private practice with more than 460 physicians and 210 locations across the state.  Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 85 FDA-approved therapies, about one-third of all cancer therapies approved to date. For more information, visit www.TexasOncology.com.

Related Cancer Centers